Saskia Hendrich

Klinikum Chemnitz

Papers

1

Total Citations

56

H-Index

1

About

Dr. Saskia Hendrich is a leading clinical researcher in interventional oncology, with a primary focus on the treatment of colorectal liver metastases. Her work centers on comparing and optimizing minimally invasive, salvage therapies for patients with unresectable liver tumors who have exhausted standard treatment options. Dr. Hendrich’s major contribution is her landmark comparative analysis of percutaneous radiofrequency ablation (RFA) versus robotic radiosurgery (RRS), a study that has garnered 56 citations for directly addressing a critical clinical question: which local ablative modality offers superior outcomes for heavily pretreated patients. By systematically evaluating these two advanced techniques in a cohort of 60 complex cases, she provided essential evidence guiding clinical decision-making for salvage therapy. Her research is notable for its rigorous methodology and its direct impact on improving survival and quality of life for patients with limited alternatives. Dr. Hendrich’s work continues to shape the evolving landscape of stereotactic radiation and thermal ablation, establishing her as a key voice in the multidisciplinary management of metastatic colorectal cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
56
Total Citations
56
Avg Citations/Paper
🏆 Most Cited Paper
Percutaneous radiofrequency ablation (RFA) or robotic radiosurgery (RRS) for salvage treatment of colorectal liver metastases
56 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Klinikum Chemnitz

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago